Viewing research peptides. User acknowledges these products are not for human nor veterinary use. Review Legal Waiver →

The NAD+ Sirtuin & Longevity Research Stack provides a comprehensive multi-analyte research protocol pairing pure beta-NAD+ (500mg), Beta-Nicotinamide Mononucleotide (500mg), and Nicotinamide Riboside (500mg). In comparative laboratory assays, this protocol enables researchers to evaluate differential cell-entry kinetics, NRK vs. NMNAT enzymatic flux rates, and relative sirtuin (SIRT1-7) deacetylation potencies across simultaneous cell cultures. Analytical purity ≥99.0% verified across all components. Strictly for laboratory research.

Chemical & Analytical Specifications

Compound Identifier NAD+ Sirtuin & Longevity Research Stack
Sequence / Structure beta-NAD+ (500mg) + NMN (500mg) + NR (500mg) Multi-Analyte Fleet
Molecular Formula C21H27N7O14P2 + C11H15N2O8P + C11H15ClN2O5
Molecular Weight 663.43 + 334.22 + 290.70 g/mol
CAS Number 53-84-9 / 1094-61-7 / 23111-00-4
Purity Specification ≥99.0% (HPLC & Mass Spectrometry)
Supplied Format Multi-vial laboratory research stack
Research Classification Multi-pathway NAD+ replenishment & sirtuin activation inquiry

Laboratory Handling & Solvent Protocols

To preserve structural integrity and peptide purity, lyophilized materials should be maintained at -20°C in an airtight container protected from ambient moisture and light. Reconstitution should be conducted under sterile conditions using bacteriostatic water (0.9% benzyl alcohol) or sterile laboratory saline. Allow the diluent to run gently down the interior vial wall; avoid vigorous shaking or vortexing to prevent shear-induced degradation. Reconstituted aliquots must be stored at 2°C to 8°C and evaluated within 28 to 30 days.

REGULATORY COMPLIANCE NOTICE All èvelan research products are strictly synthesized and supplied for laboratory research, analytical characterization, and scientific assay evaluation only. These materials are not intended, formulated, or approved for human, clinical, veterinary, or diagnostic application. Distribution is restricted to authorized personnel who affirm adherence to relevant institutional and laboratory safety protocols.

NAD+ Sirtuin & Longevity Research Stack

G$57,800.00

Research Pathways & Profile

The NAD+ Sirtuin & Longevity Research Stack provides a comprehensive multi-analyte research protocol pairing pure beta-NAD+ (500mg), Beta-Nicotinamide Mononucleotide (500mg), and Nicotinamide Riboside (500mg). In comparative laboratory assays, this protocol enables researchers to evaluate differential cell-entry kinetics, NRK vs. NMNAT enzymatic flux rates, and relative sirtuin (SIRT1-7) deacetylation potencies across simultaneous cell cultures. Analytical purity ≥99.0% verified across all components. Strictly for laboratory research.

Format & Concentration: 3-Vial Triad (1x NAD+ 500mg + 1x NMN 500mg + 1x NR 500mg)
≥99% HPLC Analytical Standard
Synthesized in Certified Facility
Direct Express Lab Fulfillment
Analytical Specifications & Sequence

Sequence: beta-NAD+ (500mg) + NMN (500mg) + NR (500mg) Multi-Analyte Fleet | Formula: C21H27N7O14P2 + C11H15N2O8P + C11H15ClN2O5 | Molecular Weight: 663.43 + 334.22 + 290.70 g/mol | CAS Number: 53-84-9 / 1094-61-7 / 23111-00-4 | Purity: ≥99.0% (RP-HPLC, ESI-MS) | Sterile Lyophilized Formulation.

Handling, Solvent & Storage Guidelines

Laboratory Assay Standard. Storage: -20°C (lyophilized powder, protected from light) or 2°C to 8°C (short-term reconstituted solution). Reconstitution: Bacteriostatic water (0.9% benzyl alcohol) via sterile interior wall flow without vortexing. Strictly prohibited for human, veterinary, or clinical use.

1All peptide compounds cataloged are intended exclusively for laboratory research, biochemical assays, and analytical characterization. Strictly not for human, veterinary, diagnostic, or therapeutic administration.
2Analytical purity (≥99%) is validated via High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS). Compound integrity is dependent on adherence to cold-chain storage and inert handling protocols.
3The acquiring entity assumes sole responsibility for regulatory compliance, laboratory safety protocols, and safe handling in accordance with federal, state, and local standards. èvelan expressly disclaims liability for off-label or unapproved application.
View Full Legal & Research Disclaimer →